Stephen Machatha, Chief Development Officer at Aldeyra Therapeutics, Inc. (ALDX), sold 32,082 shares at $4.74 ($152K) on 2024-08-12, disclosed to the SEC on 2024-08-14.
Open-market sale of $152k ALDX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.74 | 16,041 | $76K | 50.0% |
| 2 | $4.74 | 16,041 | $76K | 50.0% |
| Total | $4.74 avg | 32,082 | $152K | 100% |
| Filing → |